Article
5β-Dihydrotestosterone and mutant androgen receptor vulnerability in prostate cancer
2026-07-30
Abstract excerpt
<title>Abstract</title> <p>BACKGROUND Bipolar androgen therapy (BAT) exploits the paradoxical vulnerability of castration-resistant prostate cancer (CRPC) to supraphysiologic androgen. However, testosterone (T) is used clinically for BAT, which broadly activates wild-type androgen receptor (AR) in normal androgen-responsive tissues and can cause substantial systemic androgenic effects. 5β-Dihydrotestosterone (5β...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 21e4f3d1-91ae-570a-be05-1dc489c66f38
- DOI
- 10.21203/rs.3.rs-10462224/v1
